Presbyopia-correcting IOLs they way to go?

I am not convinced that using two very different types of lenses in one patient is the best way to maximize the visual system

Since our practice began offering presbyopia-correcting intraocular lenses (IOLs), we have implanted around 450 of them. One in five of our cataract and refractive lens exchange patients now chooses one of these new lenses. The AcrySof ReSTOR lens (Alcon Laboratories) accounts for 80% of our presbyopia-correcting implants, while the ReZoom (AMO) and the crystalens (eyeonics) together represent 20%.

Establish the needs of the patient

Think carefully before mixing and matching

Our results confirm this. Patients who have received the ReSTOR lenses have excellent near and distance vision and their intermediate vision is better than I had anticipated. By tracking satisfaction among patients who received bilateral ReSTOR lenses and remain in our care after surgery, we have learned that 90% never wear glasses; 100% have better than 20/40 uncorrected distance vision; and 90% see J3 or better at near. In addition, patients who use computers do better with ReSTOR lenses than has been reported. Furthermore, patients are generally satisfied with their first ReSTOR implant, but are happiest once they receive their second one. We do find these patients may need a little more light for their intermediate distance viewing, but generally they function very well under normal lighting conditions.

Related Videos
Trukera Medical rebranding ushers in new era of expansion into cornea market
Investigators report positive visual outcomes one year after monocular implantation of small aperture IOL
Investigating better indications and outcomes in laser refractive surgery
Avoiding errors when converting to DMEK
EDOF lens tech is evolving to help more patients with intermediate vision
Fixoflex ring: Prof. Pallikaris describes how to utilise the device during IOL implantation
Advancing IOL technology for treatment of presbyopia
Dexamethasone insert reduces time spent planning cataract surgery, counselling patients
Addressing gaps in vision care with a wearable diagnostic platform
Presbyopia-correcting drops provide hope for frustrated patients
Related Content
© 2023 MJH Life Sciences

All rights reserved.